Showing results (1401-1410 of 1,790) with videos related to

Sort By:
Pageof 179
Frontiers in Immunology|October 21, 2021
Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage InteractionsMai M Abdelmoaty, Pravin Yeapuri, Jatin Machhi, et al.
Journal of Geophysical Research. Atmospheres : JGR|January 2, 2023
Wildfire Smoke Influence on Cloud Water Chemical Composition at Whiteface Mountain, New YorkJamy Y Lee, Peter K Peterson, Logan R Vear, et al.
Journal of Diabetes and Its Complications|July 5, 2017
Participation in a National Lifestyle Change Program is associated with improved diabetes Control outcomesSandra L Jackson, Lisa R Staimez, Sandra Safo, et al.
Medinfo. MEDINFO|January 1, 1995
Merging terminologiesM S Tuttle, O N Suarez-Munist, N E Olson, et al.
Journal of Continuing Education in Nursing|February 22, 2011
Using high-fidelity simulation to develop nurse-physician teamsJanee M Klipfel, Matthew T Gettman, Kristine M Johnson, et al.
Genes & Development|September 20, 2017
STAT1 modulates tissue wasting or overgrowth downstream from PDGFRβChaoyong He, Shayna C Medley, Jang Kim, et al.
BMC Public Health|December 18, 2019
Elucidating knowledge and beliefs about obesity and eating disorders among key stakeholders: paving the way for an integrated approach to health promotionBianca Bullivant, Aaron R Denham, Clare Stephens, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 9, 2020
Neuroprotective Activities of Long-Acting Granulocyte-Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated MiceKatherine E Olson, Krista L Namminga, Aaron D Schwab, et al.
American Journal of Physiology. Cell Physiology|April 14, 2026
Overactive PDGFRα and PDGFRβ promote distinct phenotypes of skeletal muscle fibrosis and stiffness, with PDGFRβ also driving muscle growthMariola Gimla, Szczepan Olszewski, Jacob L Brown, et al.
Epilepsia|November 11, 2023
Long-term treatment with ganaxolone for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: Two-year open-label extension follow-upHeather E Olson, Sam Amin, Nadia Bahi-Buisson, et al.
Pageof 179